Amherst
FDA issued the fewest warnings over pharma advertising this year since 1997
December 11, 2017Sales and Marketing Amherst, FDA, advertising, cipher, orexigen, pharma
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
